TTUHSC Welcome to the HSC
HomePaul L. Foster School of MedicineOffice of ResearchBorder Health Research

Infectious Diseases

Selected Publications

  • Qingwen, J., Alkhatib, B., Cornetta, K., and Alkhatib, G. 2010. Alternate receptor usage of glucose transporter protein 1 and neuropilin 1 by the human T cell leukemia virus type 1. Virology 396 (2): 203-12
  • Altenburg, J., Qingwen, J., Alkhatib, B., and Alkhatib, G. 2010. The potent anti-HIV activity of CXCL12g correlates with efficient binding and internalization of CXCR4. Journal of Virology 84(5): 2563-72
  • Qingwen Jin, Lokesh Agrawal, L. Meyer, R. Tubiana, Ioannis Theodorou and Alkhatib, G. 2008. CCR5D32 59537-G/A Promoter Polymorphism Is Associated With Low Translational Efficiency and The Loss of The CCR5D32 Protective Effects. Journal of Virology 82(5): 2418-2426.
  • Qingwen Jin, Marsh, J., Kornetta, K., and Alkhatib, G. 2008. Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Generated by Lentivirus Vector-mediated Delivery of the CCR5D32 Gene Despite Detectable Expression of the HIV Coreceptors. Journal of General Virology 89: 2611-2621.
  • Agrawal, L., Jin, Q., Meyers, L., Tubiana. R., Theodore, I., and Alkhatib, G. 2007. CCRD32 Protein Expression and Stability are Critical for Resistance to HIV-1 in vivo. Journal of Virology 81(15): 8041-8049.
  • Altenburg, J.D., Broxmeyer, H. Jin, Q., Cooper, S., Basu, S. and Alkhatib, G. 2007. A Naturally Occurring Splice Variant of CXCL12/Stromal Cell-Derived Factor 1 is a potent HIV-1 Inhibitor with Weak Chemotaxis and Cell Survival Activities. Journal of Virology 81(15): 8140-8148.
  • Agrawal, L., VanHorn-Ali, Berger, EA and Alkhatib G. 2004. Specific Inhibition of HIV-1 Coreceptor Activity by Synthetic Peptides Corresponding to the Predicted Extracellular Loops of CCR5. BLOOD 103(4): 1211-1217.
©